Monday, July 24, 2017

New Therapies in Alzheimer's Disease: A Review of the Similarities and Differences



Alzheimer's disease continues to increase as the population ages and expected life span increases. The disease has profound effects on resources to care for this end of life phenomenon.  The emotional and financial impacts are catastrophic on family, loved ones, caregivers and the social network as well as government funded long term care.   Many new "memory centers" are emerging as well.



Early diagnosis is suspected by cognitive changes, behavioral changes and observation. Confirmation studies such as fMRi and CT scans can confirm changes such as amyloid plaques, and cerebral atrophy.  However Alzheimer's disease can be mimicked by other degenerative disorders.




In an outstanding professional continuing medical education course the author gives an complete story for those interested in Alzheimer's Disease.  He also elaborates on new treatments to ameliorate and slows down progress.  For those interested in the pathology and biochemical changes his lecture extends to that domain as well.





Marwan Sabbagh, MD

Karsten Solheim Chair for Dementia; Professor of Neurology; Director of the Alzheimer's and Memory Disorders Division, Barrow Neurological Institute; Research Professor of Neurology, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona


The video and transcript are available separately.  There is also a slide deck 

Currently there is no treatment that will roll back the effects of AD.  Current treatments will extend the time period for progressive decline.



New Therapies in Alzheimer's Disease: A Review of the Similarities and Differences (Transcript) 
Post a Comment